Write in a clean editor, then format for Therapeutic Advances in Endocrinology and Metabolism in one click — DocuGuru applies the official SAGE template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Therapeutic Advances in Endocrinology and Metabolism is a peer-reviewed journal published by SAGE, covering Diabetes Treatment and Management, Diabetes Management and Research, Diabetes, Cardiovascular Risks, and Lipoproteins.
| Publisher | SAGE |
|---|---|
| Reference style | Author–year (Harvard) Author–year — (Smith, 2023) in the text Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Therapeutic Advances in Endocrinology and Metabolism, 12(3), pp. 45–58.
Formats any DOI in Therapeutic Advances in Endocrinology and Metabolism style. No sign-up. |
| Publishes research in | Diabetes Treatment and Management Diabetes Management and Research Diabetes, Cardiovascular Risks, and Lipoproteins Thyroid Disorders and Treatments Pancreatic function and diabetes |
| ISSN | 2042-0188 |
| Citation impact (2-yr) | 5.5 |
| h-index | 61 |
| i10-index | 354 |
| Total citations | 16,518 |
| Article processing charge | $2,300 |
| Open access | Yes |
| Top institutions publishing here | Harvard University |
| Journal website | us.sagepub.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Diabetic foot complications are the most common occurring problems throughout the globe, resulting in devastating economic crises for the patients, families and society. Diabetic foot ulcers (DFUs) have a neuropathic origin with a progressive prevalence rate in developing countries compared with developed countries among diabetes mellitus patients. Diabetic patients that are of greatest risk of…
Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have emerged as promising therapeutic agents with potent anti-inflammatory properties and diverse clinical implications. This in-depth review article explores the mechanisms behind the anti-inflammatory actions of GLP-1RAs and assesses their prospective applicability in a wide range of disease scenarios. The current review establishes the significance of comprehending the anti-inflammatory…
Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are attractive options for the treatment of type 2 diabetes (T2D) because they effectively lower A1C and weight while having a low risk of hypoglycemia. Some also have documented cardiovascular benefit. The GLP-1 RA class has grown in the last decade, with several agents available for use in the…
Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are attractive options for the treatment of type 2 diabetes (T2D) because they effectively lower A1C and weight while having a low risk of hypoglycemia. The GLP-1 RA class has grown in the last decade with several agents available for use in the US and Europe and several more…
Background: Although the health benefits of regular physical activity and exercise are well established and have been incorporated into national public health recommendations, there is a relative lack of understanding pertaining to the harmful effects of physical inactivity. Experimental paradigms including complete immobilization and bed rest are not physiologically representative of sedentary living. A useful…
Environment and Planning A: Economy and Space
Exceptional Children
Human Factors: The Journal of the Human Factors and Ergonomics Society
Journal of Cerebral Blood Flow & Metabolism
Journal of Health and Social Behavior
Journal of Management
Journal of Psychopharmacology
Journal of Teacher Education
